{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:03:16Z","timestamp":1791028996418,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:00:00Z","timestamp":1293062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:00:00Z","timestamp":1293062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>As a group, women who carry germline mutations in partner and localizer of breast cancer 2 susceptibility protein (<jats:italic>PALB2<\/jats:italic>) are at increased risk of breast cancer. Little is known about by how much or whether risk differs by mutation or family history, owing to the paucity of studies of cases unselected for family history.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We screened 1,403 case probands for <jats:italic>PALB2<\/jats:italic> mutations in a population-based study of Australian women with invasive breast cancer stratified by age at onset. The age-specific risk of breast cancer was estimated from the cancer histories of first- and second-degree relatives of mutation-carrying probands using a modified segregation analysis that included a polygenic modifier and was conditioned on the carrier case proband. Further screening for <jats:italic>PALB2<\/jats:italic> c.3113G &gt; A (W1038X) was conducted for 779 families with multiple cases of breast cancer ascertained through family cancer clinics in Australia and New Zealand and 764 population-based controls.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>We found five independent case probands in the population-based sample with the protein-truncating mutation <jats:italic>PALB2<\/jats:italic> c.3113G &gt; A (W1038X); 2 of 695 were diagnosed before age 40 years and 3 of 708 were diagnosed when between ages 40 and 59 years. Both of the two early-onset carrier case probands had very strong family histories of breast cancer. Further testing found that the mutation segregated with breast cancer in these families. No c.3113G &gt; A (W1038X) carriers were found in 764 population-based unaffected controls. The hazard ratio was estimated to be 30.1 (95% confidence interval (CI), 7.5 to 120; <jats:italic>P<\/jats:italic> &lt; 0.0001), and the corresponding cumulative risk estimates were 49% (95% CI, 15 to 93) to age 50 and 91% (95% CI, 44 to 100) to age 70. We found another eight families carrying this mutation in 779 families with multiple cases of breast cancer ascertained through family cancer clinics.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The <jats:italic>PALB2<\/jats:italic> c.3113G &gt; A mutation appears to be associated with substantial risks of breast cancer that are of clinical relevance.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2796","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T19:44:46Z","timestamp":1294256686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["A PALB2 mutation associated with high risk of breast cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Melissa C","family":"Southey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi L","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G","family":"Dowty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice A","family":"Odefrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Sabbaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Apicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham B","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Winship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Baglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham G","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"kConFab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Breast Cancer Family Registry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"key":"2771_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.2007.53","volume":"40","author":"MR Stratton","year":"2008","unstructured":"Stratton MR, Rahman N: The emerging landscape of breast cancer susceptibility. Nat Genet. 2008, 40: 17-22. 10.1038\/ng.2007.53.","journal-title":"Nat Genet"},{"key":"2771_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006, 38: 873-875. 10.1038\/ng1837.","journal-title":"Nat Genet"},{"key":"2771_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 2006, 38: 1239-1241. 10.1038\/ng1902.","journal-title":"Nat Genet"},{"key":"2771_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007, 39: 165-167. 10.1038\/ng1959.","journal-title":"Nat Genet"},{"key":"2771_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/bcr2099","volume":"10","author":"GB Byrnes","year":"2008","unstructured":"Byrnes GB, Southey MC, Hopper JL: Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?. Breast Cancer Res. 2008, 10: 208-10.1186\/bcr2099.","journal-title":"Breast Cancer Res"},{"key":"2771_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/humu.20415","volume":"27","author":"JL Bernstein","year":"2006","unstructured":"Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P: Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T > G and c.1066-6T > G (IVS10-6T > G) from the Breast Cancer Family Registry. Hum Mutat. 2006, 27: 1122-1128. 10.1002\/humu.20415.","journal-title":"Hum Mutat"},{"key":"2771_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ajhg.2009.08.018","volume":"85","author":"SV Tavtigian","year":"2009","unstructured":"Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, Lesueur F, Byrnes GB, Chuang SC, Forey N, Feuchtinger C, Gioia L, Hall J, Hashibe M, Herte B, McKay-Chopin S, Thomas A, Vall\u00e9e MP, Voegele C, Webb PM, Whiteman DC, Australian Cancer Study; Breast Cancer Family Registries (BCFR); Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab), Sangrajrang S, Hopper JL, Southey MC, Andrulis IL, John EM, Chenevix-Trench G: Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet. 2009, 85: 427-446. 10.1016\/j.ajhg.2009.08.018.","journal-title":"Am J Hum Genet"},{"key":"2771_CR8","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-08-0210","volume":"14","author":"H Erkko","year":"2008","unstructured":"Erkko H, Dowty JG, Nikkil\u00e4 J, Syrj\u00e4koski K, Mannermaa A, Pylk\u00e4s K, Southey MC, Holli K, Kallioniemi A, Jukkola-Vuorinen A, Kataja V, Kosma VM, Xia B, Livingston DM, Winqvist R, Hopper JL: Penetrance analysis of the PALB2 c.1592delT founder mutation. Clin Cancer Res. 2008, 14: 4667-4671. 10.1158\/1078-0432.CCR-08-0210.","journal-title":"Clin Cancer Res"},{"key":"2771_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/A:1008886328352","volume":"9","author":"MR McCredie","year":"1998","unstructured":"McCredie MR, Dite GS, Giles GG, Hopper JL: Breast cancer in Australian women under the age of 40. Cancer Causes Control. 1998, 9: 189-198. 10.1023\/A:1008886328352.","journal-title":"Cancer Causes Control"},{"key":"2771_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0960-9776(94)90003-5","volume":"3","author":"JL Hopper","year":"1994","unstructured":"Hopper JL, Giles GG, McCredie MR, Boyle P: Background rational and protocol for a case-control-family study of breast cancer. Breast. 1994, 3: 79-86. 10.1016\/0960-9776(94)90003-5.","journal-title":"Breast"},{"key":"2771_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/oxfordjournals.jncimonographs.a024232","volume":"26","author":"JL Hopper","year":"1999","unstructured":"Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MR, Giles GG: Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Cooperative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr. 1999, 26: 95-100.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2771_CR12","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1186\/bcr801","volume":"6","author":"EM John","year":"2004","unstructured":"John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D, Breast Cancer Family Registry: The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004, 6: R375-R389. 10.1186\/bcr801.","journal-title":"Breast Cancer Res"},{"key":"2771_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","volume":"95","author":"GS Dite","year":"2003","unstructured":"Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL: Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst. 2003, 95: 448-457. 10.1093\/jnci\/95.6.448.","journal-title":"J Natl Cancer Inst"},{"key":"2771_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ejca.2007.01.011","volume":"43","author":"LD Smith","year":"2007","unstructured":"Smith LD, Tesoriero AA, Ramus SJ, Dite G, Royce SG, Giles GG, McCredie MR, Hopper JL, Southey MC: BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study. Eur J Cancer. 2007, 43: 823-827. 10.1016\/j.ejca.2007.01.011.","journal-title":"Eur J Cancer"},{"key":"2771_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.bjc.6690008","volume":"79","author":"MC Southey","year":"1999","unstructured":"Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MR, Hopper JL, Venter DJ: BRCA1 mutations and other sequence variants in a population based sample of Australian women with breast cancer. Br J Cancer. 1999, 79: 34-39. 10.1038\/sj.bjc.6690008.","journal-title":"Br J Cancer"},{"key":"2771_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/humu.10097","volume":"20","author":"IL Andrulis","year":"2002","unstructured":"Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS, Cooperative Family Registry for Breast Cancer studies: Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat. 2002, 20: 65-73. 10.1002\/humu.10097.","journal-title":"Hum Mutat"},{"key":"2771_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","volume":"94","author":"G Chenevix-Trench","year":"2002","unstructured":"Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, D\u00f6rk T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002, 94: 205-215.","journal-title":"J Natl Cancer Inst"},{"key":"2771_CR18","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/bcr644","volume":"5","author":"C Apicella","year":"2003","unstructured":"Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL: Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res. 2003, 5: R206-R216. 10.1186\/bcr644.","journal-title":"Breast Cancer Res"},{"key":"2771_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-008-0153-8","volume":"116","author":"SL Neuhausen","year":"2009","unstructured":"Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB, Breast Cancer Family Registry: BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat. 2009, 116: 379-386. 10.1007\/s10549-008-0153-8.","journal-title":"Breast Cancer Res Treat"},{"key":"2771_CR20","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","volume":"70","author":"J Mouchawar","year":"2010","unstructured":"Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC: Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study. Cancer Res. 2010, 70: 4795-4800. 10.1158\/0008-5472.CAN-09-0851.","journal-title":"Cancer Res"},{"key":"2771_CR21","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr1377","volume":"8","author":"GJ Mann","year":"2006","unstructured":"Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G, Kathleen Cuningham Consortium for Research in Familial Breast Cancer: Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006, 8: R12-10.1186\/bcr1377.","journal-title":"Breast Cancer Res"},{"key":"2771_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/pros.20729","volume":"68","author":"M Tischkowitz","year":"2008","unstructured":"Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cooney KA: Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Prostate. 2008, 68: 675-678. 10.1002\/pros.20729.","journal-title":"Prostate"},{"key":"2771_CR23","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/humu.20949","volume":"30","author":"T Nguyen-Dumont","year":"2009","unstructured":"Nguyen-Dumont T, Calvez-Kelm FL, Forey N, McKay-Chopin S, Garritano S, Gioia-Patricola L, De Silva D, Weigel R, Sangrajrang S, Lesueur F, Tavtigian SV, Breast Cancer Family Registries (BCFR); Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab): Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis. Hum Mutat. 2009, 30: 884-890. 10.1002\/humu.20949.","journal-title":"Hum Mutat"},{"key":"2771_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.clinbiochem.2009.07.010","volume":"42","author":"J Jim\u00e9nez Ide","year":"2009","unstructured":"Jim\u00e9nez Ide J, Esteban Carde\u00f1osa E, Palanca Suela S, Barrag\u00e1n Gonz\u00e1lez E, Bolufer Gilabert P, on behalf of the Group of Cancer Genetic Counselling Program of Valencia Community: Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers. Clin Biochem. 2009, 42: 1572-1576.","journal-title":"Clin Biochem"},{"key":"2771_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1515\/CCLM.1998.045","volume":"36","author":"C Orlando","year":"1998","unstructured":"Orlando C, Pinzani P, Pazzagli M: Developments in quantitative PCR. Clin Chem Lab Med. 1998, 36: 255-269. 10.1515\/CCLM.1998.045.","journal-title":"Clin Chem Lab Med"},{"key":"2771_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2004.03.012","volume":"216","author":"LD Ratnasinghe","year":"2004","unstructured":"Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, Dawsey SM, Mark SD, Taylor PR: Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett. 2004, 216: 157-164. 10.1016\/j.canlet.2004.03.012.","journal-title":"Cancer Lett"},{"key":"2771_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cgh.2006.01.002","volume":"4","author":"MA Jenkins","year":"2006","unstructured":"Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St John DJ, Jass JR, Giles GG, Hopper JL, Southey MC: Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol. 2006, 4: 489-498. 10.1016\/j.cgh.2006.01.002.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2771_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/gepi.1370050611","volume":"5","author":"K Lange","year":"1998","unstructured":"Lange K, Weeks D, Boehnke M: Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol. 1998, 5: 471-472. 10.1002\/gepi.1370050611.","journal-title":"Genet Epidemiol"},{"key":"2771_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gepi.1014","volume":"21","author":"AC Antoniou","year":"2001","unstructured":"Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D: Evidence for further breast cancer susceptibility genes in additional to BRCA1 and BRCA2 in a population based study. Genet Epidemiol. 2001, 21: 1-18. 10.1002\/gepi.1014.","journal-title":"Genet Epidemiol"},{"key":"2771_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/S0001867800029475","volume":"10","author":"C Cannings","year":"1978","unstructured":"Cannings C, Thompson EA, Skolnick MH: Probability functions on complex pedigrees. Adv Appl Prob. 1978, 10: 26-61. 10.2307\/1426718.","journal-title":"Adv Appl Prob"},{"key":"2771_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21750-5","volume-title":"Mathematical and Statistical Methods for Genetic Analysis","author":"K Lange","year":"2002","unstructured":"Lange K: Mathematical and Statistical Methods for Genetic Analysis. 2002, New York: Springer, 2","edition":"2"},{"key":"2771_CR32","volume-title":"Breast cancer in Australia: an overview","author":"Australian Institute of Health and Welfare and National Breast Cancer Centre","year":"2006","unstructured":"Australian Institute of Health and Welfare and National Breast Cancer Centre: Breast cancer in Australia: an overview. 2006, [http:\/\/www.aihw.gov.au\/publications\/can\/bca06\/bca06.pdf]"},{"key":"2771_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","volume":"86","author":"AC Antoniou","year":"2002","unstructured":"Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer. 2002, 86: 76-83. 10.1038\/sj.bjc.6600008.","journal-title":"Br J Cancer"},{"key":"2771_CR34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72: 1117-1130. 10.1086\/375033.","journal-title":"Am J Hum Genet"},{"key":"2771_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature05609","volume":"446","author":"H Erkko","year":"2007","unstructured":"Erkko H, Xia B, Nikkil\u00e4 J, Schleutker J, Syrj\u00e4koski K, Mannermaa A, Kallioniemi A, Pylk\u00e4s K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R: A recurrent mutation in PALB2 in Finnish cancer families. Nature. 2007, 446: 316-319. 10.1038\/nature05609.","journal-title":"Nature"},{"key":"2771_CR36","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA: Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res. 2007, 9: R83-10.1186\/bcr1828.","journal-title":"Breast Cancer Res"},{"key":"2771_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10689-009-9295-z","volume":"9","author":"L Papi","year":"2010","unstructured":"Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D: A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer. 2010, 9: 181-185. 10.1007\/s10689-009-9295-z.","journal-title":"Fam Cancer"},{"key":"2771_CR38","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-008-9945-0","volume":"113","author":"MJ Garc\u00eda","year":"2009","unstructured":"Garc\u00eda MJ, Fern\u00e1ndez V, Osorio A, Barroso A, Llort G, L\u00e1zaro C, Blanco I, Cald\u00e9s T, de la Hoya M, Ram\u00f3ny Cajal T, Alonso C, Tejada MI, San Rom\u00e1n C, Robles-D\u00edaz L, Urioste M, Ben\u00edtez J: Analysis of FANCB and FANCN\/PALB2 Fanconi Anemia genes in BRCA1\/2-negative Spanish breast cancer families. Breast Cancer Res Treat. 2009, 113: 545-551.","journal-title":"Breast Cancer Res Treat"},{"key":"2771_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assn. 1958, 53: 457-481. 10.2307\/2281868.","journal-title":"J Am Stat Assn"},{"key":"2771_CR40","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008, 98: 1457-1466. 10.1038\/sj.bjc.6604305.","journal-title":"Br J Cancer"},{"key":"2771_CR41","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA, Noll WW: BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009, 115: 2222-2233. 10.1002\/cncr.24200.","journal-title":"Cancer"},{"key":"2771_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/scbi.2001.0392","volume":"11","author":"JL Hopper","year":"2001","unstructured":"Hopper JL: Genetic epidemiology of female breast cancer. Semin Cancer Biol. 2001, 11: 367-374. 10.1006\/scbi.2001.0392.","journal-title":"Semin Cancer Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2796\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:48:33Z","timestamp":1728384513000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,23]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,12]]}},"alternative-id":["2771"],"URL":"https:\/\/doi.org\/10.1186\/bcr2796","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,23]]},"assertion":[{"value":"26 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R109"}}